Full programme

Session B.06: Virus and Host
Wednesday 3 May 2017 17:00 - 18:15

Chairs: Luka Cicin-Sain & Chris Benedict

17:00 - 17:30
Invited Lecture: Antibody and/or T-cell driven design for a protective HCMV vaccine? Daniele Lilleri, Researcher Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
17:30 - 17:45
The endothelin B receptor is critical for human cytomegalovirus infection in endothelial cells and a potential target for anti-viral therapy Masany Jung Karolinska Insititute, Stockholm, Sweden
17:45 - 18:00
Late-rising CD4 T cells resolve CMV persistence Chris Benedict, Associate Professor La Jolla Institute for Allergy and Immunology, La Jolla, United States of America
18:00 - 18:15
In Wildtype HCMV, the Pentameric Complex Drives Efficient Direct Cell-Cell Transmission that is Resistant to Host Immune Defenses Richard Stanton Cardiff University, Cardiff, United Kingdom
CMV 2017: the 6th International congenital CMV conference/16th International CMV/betaherpesvirus workshop in 2017<